Novo Nordisk

“Novo Nordisk announced on Feb. 24 it will cut U.S. list prices for Wegovy by 50% and Ozempic by 35%, bringing both to $675 a month effective Jan. 1, 2027”

“700 million. That’s how many impressions Lilly garnered on its Zepbound ad campaign since it began airing in late April, Novo Nordisk alleged in the lawsuit.”

“Novo’s suit says the trial showed results that are “clinically consistent” with Lilly’s most “methodologically rigorous” trial of Zepbound. Novo Nordisk’s lawsuit cites a study that shows its higher …”

“clinical trials of more than 4,000 adults, including Indian participants, showed better HbA1c reduction than daily basal insulin.”

“which often delays insulin initiation by seven to nine years.”

“India is the seventh country to launch Awiqli and the company hopes the treatment will remove psychological and physical barriers that prevent many patients from starting insulin therapy.”

“Novo Nordisk said Awiqli, known generically as insulin icodec, simplifies insulin therapy by reducing the number of injections from 365 a year to just 52, while providing blood sugar control comparab…”

“ordering a 25% price cut in all medicines.”

“Novo Nordisk claims it is owed $36m (£24.9m) dollars by the Greek state.”

“In a 4-year study, adults maintained an average weight loss of 10% throughout.”